Desmoplasia and Chemoresistance in Pancreatic Cancer

Desmoplasia and Chemoresistance in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) occurs mainly in people older than 50 years of age. Although great strides have been taken in treating PDAC over the past decades its incidence nearly equals its mortality rate and it was quoted as the 4th leading cause of cancer deaths in the U.S. in 2012. T...

Full description

Bibliographic Details
Main Authors: Marvin Schober, Ralf Jesenofsky, Ralf Faissner, Cornelius Weidenauer, Wolfgang Hagmann, Patrick Michl, Rainer L. Heuchel, Stephan L. Haas, J.-Matthias Löhr
Format: Article
Language:English
Published: MDPI AG 2014-10-01
Series:Cancers
Subjects:
pancreatic cancer
desmoplasia
drug resistance
SFM-DR
CAM-DR
de novo resistance
cancer stem cells
matrix
future therapies
Online Access:http://www.mdpi.com/2072-6694/6/4/2137

Internet

http://www.mdpi.com/2072-6694/6/4/2137

Similar Items